P42684 (ABL2_HUMAN) Homo sapiens (Human)
Tyrosine-protein kinase ABL2 UniProtKBInterProSTRINGInteractive Modelling
1182 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 10; Isoform 8)
It is possible new templates exist for this target since these models were created.
Available Structures
9 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Lysozyme contamination facilitates crystallization of a hetero-trimericCortactin:Arg:Lysozyme compl… |
Heteromer P00698; Q60598; | |||||
| Assess | ||||||
| The crystal structure of human ABL2 in complex with 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2… | monomer | 1×DKI; | ||||
| Assess | ||||||
| The crystal structure of human ABL2 in complex with GLEEVEC | monomer | 2×STI; | ||||
| Assess | ||||||
| HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680 | monomer | 2×NA; 1×VX6; 1×CL; | ||||
| Assess | ||||||
| Solution structure of C-terminal Domain of Tyrosine-protein kinase ABL2 from Homo sapiens, Northeas… | monomer | |||||
| Assess | ||||||
| Solution structure of the human ABL2 SH2 domain | monomer | |||||
| Assess | ||||||
| Crystal structure of Arg SH2 domain | monomer | 1×CL; | ||||
| Assess | ||||||
| Abl2 SH3 pTyr116/161 | monomer | 1×SO4; | ||||
| Assess | ||||||
| Abl2 SH3 | monomer | |||||
| Assess | ||||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2kk1.1.A | monomer | 0.81 | 99.20 | |||
| Assess | ||||||
| 1opk.1.A | monomer | 0.79 | 1×MYR; | 88.66 | ||
| Assess | ||||||
| 1opl.2.A | monomer | 0.77 | 1×P16; | 88.87 | ||
| Assess | ||||||
| 1y57.1.A | monomer | 0.69 | 44.55 | |||
| Assess | ||||||